FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Fixemer

Research Profile

Disorders

Anatomy

Prostate

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Precancerous Conditions

Co-author Network

Publications

TOP 3
Dominik Lermen; Brunhilde Blömeke; Robert Browne; Ann Clarke; Paul W Dyce; Thomas Fixemer; Günter R Fuhr; William V Holt; Katarina Jewgenow; Rhiannon E Lloyd; Stefan Lötters; Martin Paulus; Gordon McGregor Reid; Daniel H Rapoport; David Rawson; Jennifer Ringleb; Oliver A Ryder; Gabriele Spörl; Thomas Schmitt; Michael Veith; Paul Müller
Cryobanking of viable biomaterials: implementation of new strategies for conservation purposes.
Helmut Bonkhoff; Thomas Fixemer
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
Helmut Bonkhoff; Thomas Fixemer
[Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Fixemer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Dominik Lermen; Brunhilde Blömeke; Robert Browne; Ann Clarke; Paul W Dyce; Thomas Fixemer; Günter R Fuhr; William V Holt; Katarina Jewgenow; Rhiannon E Lloyd; Stefan Lötters; Martin Paulus; Gordon McGregor Reid; Daniel H Rapoport; David Rawson; Jennifer Ringleb; Oliver A Ryder; Gabriele Spörl; Thomas Schmitt; Michael Veith; Paul Müller
Cryobanking of viable biomaterials: implementation of new strategies for conservation purposes.
Molecular ecology 2009;18(6):1030-3.
2005: Helmut Bonkhoff; Thomas Fixemer
[Implications of estrogens and their receptors for the development and progression of prostate cancer].
Der Pathologe 2005;26(6):461-8.
2005: Helmut Bonkhoff; Thomas Fixemer
[Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype].
Der Pathologe 2005;26(6):453-60.
2004: Ulrich Wissenbach; Barbara A Niemeyer; Nina Himmerkus; Thomas Fixemer; Helmut Bonkhoff; Veit Flockerzi
TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.
Biochemical and biophysical research communications 2004;322(4):1359-63.
2004: Helmut Bonkhoff; Thomas Fixemer
[Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
Der Urologe. Ausg. A 2004;43(7):836-42.
2003: Helmut Bonkhoff; H Motherby; Thomas Fixemer
[New insights into the role of estogens and their receptors in prostate cancer].
Der Urologe. Ausg. A 2003;42(12):1594-601.
2003: Thomas Fixemer; Ulrich Wissenbach; Veit Flockerzi; Helmut Bonkhoff
Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.
Oncogene 2003;22(49):7858-61.
2003: Joern Kamradt; Carsten Drosse; Sascha Kalkbrenner; Volker Rohde; Ramona Lensch; Jan Lehmann; Thomas Fixemer; Helmut Bonkhoff; Michael Stoeckle; Bernd Wullich
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
Laboratory investigation; a journal of technical methods and pathology 2003;83(5):623-33.
2003: Thomas Fixemer; Klaus Remberger; Helmut Bonkhoff
Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
The Prostate 2003;54(2):79-87.
2002: Thomas Fixemer; Klaus Remberger; Helmut Bonkhoff
Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
The Prostate 2002;53(2):118-23.
2001: Helmut Bonkhoff; Thomas Fixemer; I Hunsicker; Klaus Remberger
Progesterone receptor expression in human prostate cancer: correlation with tumor progression.
The Prostate 2001;48(4):285-91.
2001: Ulrich Wissenbach; Barbara A Niemeyer; Thomas Fixemer; Arne Schneidewind; Claudia Trost; A Cavalie; Katrin Reus; Eckart Meese; Helmut Bonkhoff; Veit Flockerzi
Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer.
The Journal of biological chemistry 2001;276(22):19461-8.
2000: Volker Rohde; HP Sattler; T Bund; Helmut Bonkhoff; Thomas Fixemer; C Bachmann; Ramona Lensch; Gerhard Unteregger; Michael Stoeckle; Bernd Wullich
Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4803-9.
2000: Helmut Bonkhoff; Thomas Fixemer; I Hunsicker; Klaus Remberger
Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer.
The Prostate 2000;45(1):36-41.
1999: Helmut Bonkhoff; Thomas Fixemer; I Hunsicker; Klaus Remberger
Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.
The American journal of pathology 1999;155(2):641-7.
1999: Helmut Bonkhoff; Thomas Fixemer; I Hunsicker; Klaus Remberger
Simultaneous detection of DNA fragmentation (apoptosis), cell proliferation (MIB-1), and phenotype markers in routinely processed tissue sections.
Virchows Archiv : an international journal of pathology 1999;434(1):71-3.
1998: C Pföhler; Thomas Fixemer; Volker Jung; S Dooley; Klaus Remberger; Helmut Bonkhoff
In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions.
The Prostate 1998;36(3):143-50.
1998: Helmut Bonkhoff; Thomas Fixemer; Klaus Remberger
Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer.
The Prostate 1998;34(4):251-8.